Local forms of diclofenac in the treatment of acute and chronic pain

According to modern ideas, pain is a multidisciplinary problem with serious medical and socio-economic importance. The most common pain occurs in various structures of the musculoskeletal system. It is noted that the universal mechanism of acute and chronic pain is inflammation, which requires therapy with nonsteroidal anti-inflammatory drugs (NSAIDs). Data on the effectiveness and good tolerability of local NSAIDs are presented. The latest recommendations of the international Committee ESCEO 2019 on the management of patients with osteoarthritis (OA), which confirms the effectiveness and safety of local forms of NSAIDs, in connection with which, ESCEO recommends their use in elderly patients, in patients with comorbid conditions and at high risk of adverse reactions. It is also envisaged to use these drugs for the treatment of OA before the appointment of systemic NSAIDs. The results of randomized clinical trials (RCTS) and meta-analyses confirming clinical efficacy and safety in the treatment of acute and chronic pain by one of the representatives of local NSAIDs-diclofenac sodium gel are presented. Diclofenac sodium gel has been shown to be more effective than placebo in the treatment of acute and chronic pain. Good tolerability of the drug was observed in patients in different age groups, including patients older than 65 years, and in patients with comorbid conditions. The results obtained indicate the effectiveness and good tolerability of diclofenac sodium gel, including long-term, and allow the drug to be widely used as symptomatic therapy for the treatment of acute and chronic pain, including in elderly patients and patients with comorbid conditions.

local forms of nonsteroidal anti-inflammatory drugs, acute pain, chronic pain, diclofenac, diclofenac sodium gel

1. Nasonov E.L., Yakhno N.N., Karateev A.E., et al. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Rheumatology Science and Practice. 2016;54(3):247-265. (In Russ.) doi: 10.14412/1995-4484-2016-247-265.

2. Autokarala I., Kwoh C., Guermazi A. et al. Synovitis in knee osteoarthritis: a precursor of disease? Ann Rheum Dis. 2016;75(2):3905. doi: 10.1136/annrheumdis-2014-205894.

3. Haugen I.K., Boyesen P., Slatowsky-Chritensen B. et al. Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis. Ann Rheum Dis. 2012;71(3):345-50. doi: 10.1136/annrheumdis-2011-200028.

4. Glimm A.M., Werner S.G., Burmester G.R. et al. Analysis of distribution and severity of inflammation in patients with osteoarthritis compared to rheumatoid arthritis by IGGenhanced fluorescence optical imaging and musculosckeletal ulnrasound: a pilot atudy. Ann Rheum Dis. 2016;75(3):566-570. doi: 10.1136/annrheumdis-2015-207345.

5. Karateev A.E., Nasonov E.L., Yakhno N.N., Ivashkin V.T., Chichasova N.V., Alekseeva L.I., Karpov Y.A., Evseev M.A., Kukushkin M.L., Danilov A.B., Vorobyeva O.V., Amelin A.V., Novikova D.S., Drapkina O.M., Kopenkin S.S., Abuzarova G.R. Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Modern Rheumatology Journal. 2015;9(1):4-23. (In Russ.) doi: 10.14412/1996-7012-2015-1-4-23.

6. McAlindon T.E., Bannuru R.R., Sullivan M.C. et al. Osteoarthritis Cartilage. 2014;22(3):363-88. doi: 10.1016/j.joca.2014.01.003.

7. Massey T. et al. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;(6):CD007402. doi:10.1002/14651858. CD007402.pub2.

8. Derry S., Conaghan P., Da Silva J.A., Wiffen P.J., Moore R.A. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4:CD007400. doi: 10.1002/14651858.CD007400.pub3.

9. Bruyère O., Honvo G., Veronese N. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019. pii: S0049-0172(19)30043-5. doi: 10.1016/j. semarthrit.2019.04.008.

10. Nasonova V.A. Rational use of nonsteroidal anti-inflammatory drugs in rheumatology. RMZH = RMJ. 2002;10(6):302-306. (In Russ.) Available at: https://www.rmj.ru/articles/revmatologiya/Racionalynoe_primenenie_nesteroidnyh_protivovospalitelynyh_preparatov_v_ revmatologii.

11. Chichasova N.V. Place of local therapy of joints, periarticular tissues and spine in clinical practice. Consilium Medicum. 2001;3(9):426-428. (In Russ.)

12. Balcioğlu H., Tufan F. Efficacy assessment of three non-steroidal anti-inflammatory gels with three different ingredients in patients with soft tissue trauma. Biomedical Research. 2017;28(2):639-643. Available at: https://www. researchgate.net/publication/312553381_Efficacy_assessment_of_three_non-steroidal_ anti-inflammatory_gels_with_three_different_ ingredients_in_patients_with_soft_tissue_trauma.

13. Altman R.D., Dreiser R.L., Fisher C.L. et al. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, doubleblind, placebo-controlled trial. J Rheumatol. 2009;36(9):1991-1999. doi: 10.3899/ jrheum.081316.

14. Barthel H.R., Haselwood D., Longley S. et al. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39(3):203-212. doi: 10.1016/j.semarthrit.2009.09.002.

15. Baraf H.S., Gloth F.M., Barthel H.R. et al. Gold MS Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging. 2011;28(1):27-40. doi: 10.2165/11584880-000000000-00000

16. Baraf H.S., Gold M.S., Petruschke R.A., Wieman M.S. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Am J Geriatr Pharmacother. 2012;10(1):47-60. doi: 10.1016/j. amjopharm.2011.12.002.

17. Peniston J.H., Gold M.S., Wieman M.S., Alwine L.K. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012;7:517-523. doi: 10.2147/CIA. S35416.

18. Taylor R.S., Fotopoulos G., Maibach H. Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculosceletal conditions. Curr Med Res Opin. 2011;27(3):605-22. doi: 10.1185/03007995.2010.550606.